Atara Biotherapeutics (ATRA) Operating Income Growth (1y) (2014 - 2026)
Atara Biotherapeutics (ATRA) Operating Income Growth (1y) (2014 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
Op. Inc Growth (1y) (Qtr) |
| 1 |
Alterity Therapeutics |
719,706.53 Bn |
719,706.50 Bn |
- |
- |
| 2 |
Belite Bio |
55,800.00 Bn |
55,800.00 Bn |
- |
100.00% |
| 3 |
Quantum Biopharma |
18,182.30 Bn |
18,182.29 Bn |
- |
12.69% |
| 4 |
Legend Biotech |
3,154.00 Bn |
3,153.71 Bn |
242.10 Mn |
75.16% |
| 5 |
Akari Therapeutics |
1,844.30 Bn |
1,844.29 Bn |
- |
-347.04% |
| 6 |
Evaxion A |
1,567.96 Bn |
1,567.94 Bn |
- |
1.27% |
| 7 |
Psyence Biomedical |
251.43 Bn |
251.42 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
112.56 Bn |
105.31 Bn |
2.59 Bn |
80.62% |
| 9 |
Abivax |
94.37 Bn |
94.37 Bn |
- |
- |
| 10 |
Atara Biotherapeutics |
134.61 Mn |
126.21 Mn |
392,000.00 |
-108.68% |
| Date | Value |
|---|
| Mar 31, 2026 |
-108.68% |
| Dec 31, 2025 |
-158.58% |
| Sep 30, 2025 |
83.57% |
| Jun 30, 2025 |
117.54% |
| Mar 31, 2025 |
224.18% |
| Dec 31, 2024 |
79.65% |
| Sep 30, 2024 |
68.75% |
| Jun 30, 2024 |
74.47% |
| Mar 31, 2024 |
58.35% |
| Dec 31, 2023 |
20.62% |
| Sep 30, 2023 |
17.74% |
| Jun 30, 2023 |
-122.25% |
| Mar 31, 2023 |
14.96% |
| Dec 31, 2022 |
19.13% |
| Sep 30, 2022 |
0.22% |
| Jun 30, 2022 |
61.75% |
| Mar 31, 2022 |
-12.75% |
| Dec 31, 2021 |
-14.33% |
| Sep 30, 2021 |
-13.53% |
| Jun 30, 2021 |
-7.76% |
